About this trial
The goal of this case control study is to detect serum isthmin-1 level in RA patient compered to healthy control . The main questions it aims to answer are:
what is the serum isthmin-1 level in RA patient? what is the correlation between serum isthmin-1 and RA disease activity? what is the correlation between serum isthmin-1 level and MSUS finding in RA patients?
Eligibility criteria
This trial accepts healthy volunteersQualifiers
None
Disqualifiers
Patients less than 18 years old.
Patients with other autoimmune diseases.
Participants with active infections, malignancies or diabetes.
Recent hand surgery, trauma, deformity and neurological conditions affecting hand function
Trial population
Adult patients (≥18 years old) clinically diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR classification criteria.
Trial design
Case-control
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Detection of serum isthmin-1 level in RA patients compared to healthy controls.
The quantitative level of Human ISM1 will be measured with a commercial enzyme-linked immunosorbent assay(ELISA) kit.
Secondary outcomes
To correlate serum ISM1 levels with disease activity in RA
through clinical and acute phase reactant
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Amera Imam Abdel - Ghany Ahmed
Lead sponsor
Assiut University
Sponsor institution
This trial is not recruiting at the moment. You can still explore other options: